Clinical Study Results
Where can I learn more about this study?
You can find more information about this study on the websites listed below. If more information
about the study results is available, it can also be found here.
• www.clinicaltrials.gov. Once you are on this website, type “NCT02991911” into the search
box and click “Search".
• www.AstraZenecaClinicalTrials.com. Once you are on the website, type “D9320C00001”
into the search box, and click “Find a Study”.
Full Study Title: A Phase 1/1b Multicenter, Open-Label, Dose-Escalation and Dose-Expansion
Study to Evaluate the Safety, Pharmacokinetics, Immunogenicity, and Antitumor Activity of
MEDI3726 in Subjects with Metastatic Castration Resistant Prostate Cancer (mCRPC) who have
Received Prior Treatment with Abiraterone or Enzalutamide
AstraZeneca Protocol Number: D9320C00001
National Clinical Trials number: NCT02991911
MedImmune LLC sponsored this study and has its headquarters in Gaithersburg, MD, USA.
The phone number for the AstraZeneca Information Center is +1 877 240 9479.
Thank you!
Clinical study participants belong to a large community of people who take part in clinical
research around the world. They help researchers answer important health questions and find
medical treatments for patients.
The Center for Information & Study on Clinical Research
Participation (CISCRP) is a non-profit organization focused
on educating and informing the public about clinical research
participation. CISCRP is not involved in recruiting participants for
clinical studies, nor is it involved in conducting clinical studies.
CISCRP
One Liberty Square, Suite 1100 • Boston, MA 02109
1-877-MED-HERO • www.ciscrp.org
Version 1.0 2020_12_04 8